Wound therapy system with wound volume estimation

ABSTRACT

A volume of a wound is estimated using a dynamic pressure response measured during instillation of fluid to the wound using a negative pressure wound therapy system. A previously estimated wound volume may be used to detect and prevent overfill of fluid to the wound during future instillation events. For example, real-time pressure measurements may be compared to model data representative of expected pressure at a wound having a volume equal to the previously estimated wound volume, with instillation being stopped if the observed pressure varies from the expected pressure. A comparison of a total volume of fluid instilled to the wound may also be compared to the previously estimated wound volume to prevent overfill. The comparison of wound volume estimated based on an instillation event may also be compared to a wound volume estimated using other methods to provide a higher confidence wound volume estimate.

RELATED APPLICATIONS

This application is a Divisional of U.S. patent application Ser. No.16/366,308, entitled “WOUND THERAPY SYSTEM WITH WOUND VOLUMEESTIMATION,” filed Mar. 27, 2019, which is incorporated herein byreference for all purposes.

BACKGROUND

The present disclosure relates generally to a wound therapy system, andmore particularly to a wound therapy system configured to estimate avolume relative to a wound site.

Negative pressure wound therapy (NPWT) is a type of wound therapy thatinvolves applying a negative pressure to a wound site to promote woundhealing. Recent advancements in wound healing with NPWT involve applyingtopical fluids to wounds to work in combination with NPWT. However, itcan be difficult to determine the appropriate volume of instillationfluid to deliver to the wound. Additionally, it can be difficult toaccurately monitor and track healing progression of the wound over time.Accordingly, it would be advantageous to provide a system and methodthat would allow for accurate and reliable estimation of available spaceat a wound site into which instillation fluid could be delivered andestimation of the healing progression of the wound site over time.Advantageously, such a system and method would additionally allow forsuch volume determinations to be performed automatically by acontroller, could be performed at any stage during the NPWT treatment,would not require any additional time and/or steps to perform than woulda typical NPWT treatment, would allow for overfill detection and/orprevention during fluid instillation cycles, and/or could account forchanges in the type or size of removed fluid canister used over thecourse of the NPWT treatment.

SUMMARY

In one implementation of the present disclosure, a method includesoperably connecting a first end of a fluid tube to a fluid canister anda pump of a therapy device and a second end of the fluid tube to a wounddressing applied to a wound site. The pump is operated until apredetermined first negative pressure is detected. A first quantity offluid is instilled to the wound site until a first predetermined targetpressure is detected. Pressure is monitored during instillation of thefirst quantity of fluid to the wound site. A volume of the firstquantity of fluid instilled to the wound site is determined usingpressure measurements obtained from the monitored pressure e during theinstillation of the first quantity of fluid to the wound site.

According to some embodiments, the determination of the volume of thefirst quantity of fluid instilled to the wound site includes comparingthe obtained pressure measurements to model pressure decay data.According to some embodiments, the model pressure decay data isrepresentative of pressure decay within a container having a knownvolume as a predetermined quantity of fluid is instilled to thecontainer. According to some embodiments, the model pressure decay datacomprises pressure decay data for a plurality of containers having knownvolumes.

According to some embodiments, the determined volume of the firstquantity of fluid instilled to the wound site is stored. According tosome embodiments, the first predetermined target pressure isapproximately 0 mmHg. According to some embodiments, the pump isoperated until a predetermined second negative pressure is detected.According to some embodiments, a second quantity of fluid is instilledto the wound site until a second predetermined target pressure isdetected. According to some embodiments, pressure is monitored duringinstillation of the second quantity of fluid to wound site.

According to some embodiments, a volume of the second quantity of fluidinstilled to the wound site is determined using pressure measurementsobtained from the monitored pressure during the instillation of thesecond quantity of fluid to the wound site. According to someembodiments, the second predetermined target pressure is approximately 0mmHg.

According to some embodiments, the first quantity of fluid is instilledto the wound site at a predetermined flow rate. According to someembodiments, the second quantity of fluid is instilled to the wound siteat a predetermined flow rate. According to some embodiments, thedetermined volume of the second quantity of fluid instilled to the woundsite is stored. According to some embodiments, a rate of wound healingis determined by comparing the first stored volume to the second storedvolume.

In one implementation of the present disclosure, a method of preventingoverfill of fluid to a wound site includes operably connecting a firstend of a fluid tube to a fluid canister and a pump of a therapy deviceand a second end of the fluid tube to a wound dressing applied to awound site. The pump is operated to attain a predetermined firstnegative pressure. Fluid is instilled to the wound site. Pressure duringinstillation of the fluid to the wound site is monitored. Instillationof fluid to the wound site is stopped in response to a firstpredetermined target pressure being detected.

According to some embodiments, the first predetermined target pressureis 0 mmHg. According to some embodiments, a volume of the wound site isestimated prior to the instillation of fluid to the wound site.According to some embodiments, model pressure decay data representativeof pressure decay within a container having a volume equal to theestimated volume of the wound site as varying quantities of fluid areinstilled into the container is obtained. According to some embodiments,monitoring pressure includes obtaining measurements of the pressure.According to some embodiments, the obtained pressure measurements arecompared to the model pressure decay data in real-time. According tosome embodiments, an alarm is generated if the measured pressure doesnot correspond to the model pressure decay data.

According to some embodiments, a volume of the fluid instilled to thewound site is determined. According to some embodiments, the volume ofthe fluid instilled to the wound site is determined using pressuremeasurements obtained from the monitored pressure during instillation ofthe fluid to the wound site. According to some embodiments, determiningthe volume of the fluid instilled to the wound site includes comparingthe obtained pressure measurements to model pressure decay data.

According to some embodiments, the second predetermined pressure is 0mmHg. According to some embodiments, the estimated volume of the woundsite is compared to the determined volume of the fluid instilled to thewound site. According to some embodiments, an alarm is generated if theestimated volume of the wound site is not substantially the same as thedetermined volume of the fluid instilled to the wound site.

In one implementation of the present disclosure, a wound therapy systemincludes a pump, a wound dressing configured to be applied to a woundsite, a fluid tube fluidly connecting the pump to the wound dressing,and a controller. The controller is configured to monitor pressureduring instillation of a fluid to the wound site and determine a volumeof the fluid instilled to the wound site using pressure measurementsobtained from the monitored pressure during the instillation of thefluid to the wound site.

According to some embodiments, the controller is configured to determinethe volume of the fluid instilled to the wound by comparing the obtainedpressure measurements to model pressure decay data. According to someembodiments, the controller is configured to store the determined volumeof the fluid instilled to the wound site. According to some embodiments,the controller is configured to determine a volume of a fluid instilledto the wound site at each of one or more instillation events occurringduring treatment of the wound site. According to some embodiments, thecontroller is configured to store each of the determined volumes.According to some embodiments, the controller is configured to monitorhealing of the wound site based on the stored determined volumes.

According to some embodiments, the wound therapy system also includes asource of instillation fluid. The controller is further configured tooperate the pump to instill the fluid to the wound site. According tosome embodiments, the controller is configured to stop the instillationof the fluid to the wound site when a first predetermined pressure hasbeen. According to some embodiments, the controller is configured tostop the operation of the pump when a pressure of substantially 0 mmHghas been detected. According to some embodiments, the controller isfurther configured to operate the pump to evacuate air from the woundsite.

According to some embodiments, the controller is further configured tooperate the pump to evacuate air from the wound site to attain apredetermined negative pressure. Upon detecting that a pressure is equalto the predetermined negative pressure, the controller is configured tooperate the pump to instill a fluid to the wound site. The controller isconfigured to stop the instillation of fluid to the wound site upondetection that a measured pressure is equal to a predetermined targetpressure.

In one implementation of the present disclosure, a wound therapy systemincludes a pump, a wound dressing configured to be applied to a woundsite, a fluid tube fluidly connecting the pump to the wound dressing, asource of instillation fluid, and a controller. The controller isconfigured to operate to pump to instill the instillation fluid to thewound site and monitor pressure during instillation of fluid to thewound site. The controller is configured to stop the operation of thepump in response to the detection of a first predetermined pressure.

According to some embodiments, the predetermined pressure is 0 mmHg.According to some embodiments, the controller is configured to obtain anestimated volume of the wound site prior to operating the pump toinstill fluid to the wound site. According to some embodiments, thecontroller is configured to obtain pressure measurements based on thepressure monitored during the operation of the pump to instill fluid tothe wound site. According to some embodiments, the controller isconfigured to obtain model pressure decay data representative ofpressure decay within a container having a volume equal to the estimatedvolume of the wound site as fluid is instilled into the container.According to some embodiments, the controller is further configured tocompare the pressure measurements to the model pressure decay data inreal-time.

According to some embodiments, an alarm is generated if the measuredpressure does not correspond to the model pressure decay data. Accordingto some embodiments, the estimated volume of the wound site is obtainedby the controller by operating the pump to evacuate air from the woundsite.

According to some embodiments, the controller is further configured tooperate the pump to evacuate air from the wound site and monitorpressure as air is evacuated from the wound site. The controller isfurther configured to stop operation of the pump when a predeterminednegative pressure has been detected. According to some embodiments, thecontroller is configured to operate the pump to instill the instillationfluid to the wound site after the predetermined negative pressure hasbeen detected.

According to some embodiments, the controller is configured to estimatethe volume of the fluid instilled to the wound site using pressuremeasurements obtained from the monitored pressure during instillation ofthe fluid to the wound site. According to some embodiments, thecontroller is configured to compare the obtained pressure measurementsto model pressure decay data to estimate the volume of the fluidinstilled to the wound site According to some embodiments, the modelpressure decay data is representative of pressure decay within acontainer having a known volume during instillation of a fluid into thecontainer.

According to some embodiments the controller is configured to obtain anestimate of the volume of the wound site. According to some embodimentsthe estimated volume of the wound site is compared to the determinedvolume of the fluid instilled to the wound site. According to someembodiments an alarm is generated if the estimated volume of the woundsite is not substantially the same as the determined volume of the fluidinstilled to the wound site.

Those skilled in the art will appreciate that the summary isillustrative only and is not intended to be in any way limiting. Otheraspects, inventive features, and advantages of the devices and/orprocesses described herein, as defined solely by the claims, will becomeapparent in the detailed description set forth herein and taken inconjunction with the accompanying drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a block diagram of a negative pressure wound therapy systemincluding a therapy device coupled to a wound dressing via tubing,according to an exemplary embodiment.

FIG. 2 is a block diagram illustrating the negative pressure woundtherapy system of FIG. 1 in greater detail, according to an exemplaryembodiment.

FIG. 3 is a block diagram illustrating the negative pressure circuit,the removed fluid canister circuit and the wound site circuit of thenegative pressure wound therapy system of FIG. 1 in greater detail,according to an exemplary embodiment.

FIG. 4 is a block diagram illustrating a negative pressure wound therapysystem, according to an exemplary embodiment.

FIG. 5 is a flowchart of a method of using a negative pressure woundtherapy system, according to an exemplary embodiment.

FIG. 6 is a flowchart of a process for monitoring the healingprogression of a wound site over time, according to an exemplaryembodiment.

FIG. 7 is a flowchart of a method of using a negative pressure woundtherapy system, according to an exemplary embodiment.

FIG. 8 is a flowchart of a method of using a negative pressure woundtherapy system, according to an exemplary embodiment.

DETAILED DESCRIPTION Overview

Referring generally to the FIGURES, a wound therapy system is shownaccording to various exemplary embodiments. The wound therapy system mayinclude a therapy device and a wound dressing. The therapy device mayinclude an instillation fluid canister, a removable fluid canister, avalve, a pneumatic pump, an instillation pump, and a controller. Thewound dressing can be applied to a patient's skin surrounding a wound.The therapy device can be configured to deliver instillation fluid tothe wound and provide negative pressure wound therapy (NPWT) bymaintaining the wound at negative pressure. Components of the woundtherapy device, the wound dressing, and the wound site form a negativepressure circuit.

The controller may be configured to operate the pneumatic pump, theinstillation pump, and/or other controllable components of the therapydevice. According to some embodiments in which the NPWT treatmentprovided using the NPWT system includes the instillation of instillationfluid to the wound site, the controller may be configured to estimatethe volume of the wound site and/or a volume of a quantity ofinstillation fluid delivered to the wound site based on a comparison ofdynamic pressure responses observed as fluid is instilled to the woundsite to model pressure response data. Because the dynamic pressureresponses are observed simultaneously with the instillation of fluid tothe wound site, the system and methods described herein are configuredto allow the controller to estimate wound site volume without requiringany additional steps and/or time than would otherwise be required toprovide instillation therapy treatment using the NPWT system.

According to some embodiments, the wound site volume estimate based ondynamic pressure responses observed during fluid instillation may beused to verify and/or may be verified using wound site volume estimatesobtained using any other number of methods to provide the NPWT systemwith higher confidence wound site volume estimates. For example, in someembodiments, the controller may compare the wound site volume estimatedbased on dynamic pressure responses observed during fluid instillationto a wound site volume estimated based on a comparison of dynamicpressure responses observed during the purging of negative pressurewithin the entirety and/or selected portions of the negative pressurecircuit.

In various embodiments, the controller may additionally, oralternatively, be configured to prevent and/or detect overfill duringthe instillation of instillation fluid to the wound site. According tosome such embodiments, the controller may use a previously obtainedwound site volume estimate (estimated, e.g., during a prior instillationof fluid to the wound site; based on a comparison of dynamic pressureresponses observed during the purging of negative pressure from thenegative pressure circuit; etc.) as a backstop value against which thevolume of the quantity of fluid that has been instilled to the woundsite is compared to prevent overfilling the wound site with instillationfluid. In some embodiments, the previously obtained wound site volumeestimate may additionally, or alternatively, be used to identify a modelpressure decay curve representative of a dynamic pressure response thatwould be expected during the instillation of instillation fluid to thewound site to attain a predetermined target pressure, as measured, e.g.,at any one or more of the wound site, within the tubing fluid connectedthe wound site to the therapy device, within the removed fluid canister,at the therapy device, etc. In such embodiments, dynamic pressureresponse at the wound site is monitored in real-time and comparedagainst the model pressure decay curve, with deviations in the monitoredpressure at and the expected pressure based on the model decay curvebeing used to alert the controller to a possible overfill situationwhich may need to be addressed.

In some embodiments, the controller may additionally, or alternatively,estimate and monitor the volume of the wound site at a plurality oftimes during wound treatment, with the controller determining healingprogression of the wound site based on changes in the estimated woundsite volume over the course of NPWT treatment. By monitoring the healingprogression of the wound site, the controller may be configured to alerta user if the healing of the wound site is not progressing as intendedor expected. As will be understood, in some embodiments, the monitoringof changes in estimated wound site volume over time may additionallyadvantageously provide the controller with more accurate values thatallow the controller to more accurately detect and/or prevent overfillof instillation fluid to the wound site. These and other features of thewound therapy system are described in detail below.

Wound Therapy System

Referring now to FIG. 1 , a negative pressure wound therapy (NPWT)system 100 is shown according to an exemplary embodiment. The NPWTsystem 100 is shown to include a therapy device 102 fluidly connected toa wound dressing 112 via tubing 108 and 110. According to variousembodiments, a wound dressing 112 may be placed on or within the woundsite 114 and adhered or sealed to a patient's skin 116 surrounding awound site 114 using drape layer 117. Several examples of wounddressings 112 which can be used in combination with NPWT system 100 aredescribed in detail in U.S. Pat. No. 7,651,484 granted Jan. 26, 2010,U.S. Pat. No. 8,394,081 granted Mar. 12, 2013, and U.S. patentapplication Ser. No. 14/087,418 filed Nov. 22, 2013. The entiredisclosure of each of these patents and patent applications isincorporated by reference herein.

As illustrated by the block diagram of FIG. 2 , in general the therapydevice 102 includes a pneumatic pump 120, an instillation pump 122, afilter 128, and a controller 118. Pneumatic pump 120 can be fluidlycoupled to removed fluid canister 106 (e.g., via conduit 136) and can beconfigured to draw a vacuum within canister 106 by pumping air out ofcanister 106. In some embodiments, pneumatic pump 120 is configured tooperate in both a forward direction and a reverse direction. Forexample, pneumatic pump 120 can operate in the forward direction to pumpair out of canister 106 and decrease the pressure within canister 106.Pneumatic pump 120 can operate in the reverse direction to pump air intocanister 106 and increase the pressure within canister 106. Pneumaticpump 120 can be controlled by controller 118, described in greaterdetail below.

Therapy device 102 can be configured to provide negative pressure woundtherapy by reducing the pressure at wound site 114. Therapy device 102can draw a vacuum at wound site 114 (relative to atmospheric pressure)by removing wound exudate, air, and other fluids from wound site 114.Wound exudate may include fluid that filters from a patient'scirculatory system into lesions or areas of inflammation. For example,wound exudate may include water and dissolved solutes such as blood,plasma proteins, white blood cells, platelets, and red blood cells.Other fluids 121 removed from wound site 114 may include instillationfluid 105 previously delivered to wound site 114. Instillation fluid 105can include, for example, a cleansing fluid, a prescribed fluid, amedicated fluid, an antibiotic fluid, or any other type of fluid whichcan be delivered to wound site 114 during wound treatment. Instillationfluid 105 may be held in an instillation fluid canister 104 andcontrollably dispensed to wound site 114 via tubing 108. In someembodiments, instillation fluid canister 104 is detachable from therapyde vice 102 to allow canister 104 to be refilled and replaced as needed.

Instillation pump 122 can be fluidly coupled to instillation fluidcanister 104 and the wound dressing 112 via instillation tubing 108.Instillation pump 122 can be operated to deliver instillation fluid 105to wound dressing 112 and wound site 114 by pumping instillation fluid105 through instillation tubing 108. Instillation pump 122 can becontrolled by controller 118, described in greater detail below.According to some embodiments, the instillation pump 122 may be definedby all or a portion of the pneumatic pump 120.

Filter 128 can be positioned between removed fluid canister 106 andpneumatic pump 120 (e.g., along conduit 136) such that the air pumpedout of canister 106 passes through filter 128. Filter 128 can beconfigured to prevent liquid or solid particles from entering conduit136 and reaching pneumatic pump 120. Filter 128 may include, forexample, a bacterial filter that is hydrophobic and/or lipophilic suchthat aqueous and/or oily liquids will bead on the surface of filter 128.Pneumatic pump 120 can be configured to provide sufficient airflowthrough filter 128 that the pressure drop across filter 128 is notsubstantial (e.g., such that the pressure drop will not substantiallyinterfere with the application of negative pressure to wound site 114from therapy device 102).

Removed fluid canister 106 may be a component of therapy de vice 102configured to collect wound exudate and other fluids 121 removed fromwound site 114. In some embodiments, removed fluid canister 106 isdetachable from therapy device 102 to allow canister 106 to be emptiedand replaced as needed. A lower portion of canister 106 may be filledwith wound exudate and other fluids 107 removed from wound site 114,whereas an upper portion of canister 106 may be filled with air. Therapydevice 102 can be configured to draw a vacuum within canister 106 bypumping air out of canister 106. The reduced pressure within canister106 can be translated to wound dressing 112 and wound site 114 viatubing 110.

As shown in FIG. 1 , disposed along tubing 110 at a location between theremoved fluid canister 106 and the wound site 114 may be a tubing valve111 (e.g. spring-biased; duck-bill: check-valve, etc.) configured toprevent fluid flow from the removed fluid canister 106 to the wound site114.

Referring to the block diagram of FIG. 3 , removed fluid canister 106,tubing 110, conduit 136 extending between pneumatic pump 120 and removedfluid canister 106, and wound site 114 are fluidly connected to define anegative pressure circuit 200. As will be discussed in more detailbelow, the volumes of the tubing 110 and conduit 136 define knownvolumes which can be easily subtracted from or otherwise factored intocalculations of volume(s) relative to the wound site 114. As shown inFIG. 2 , according to various embodiments, a vent 132 may be providedvia which a vacuum within the negative pressure circuit 200 may bepurged.

As will be described with more reference to FIG. 8 , according to someembodiments, it may be desired to verify the volume estimated using anyof the methods described herein against a volume estimate obtained usingother methods and/or from other sources, such as, e.g. a volumeestimated based on measurements obtained during a drawdown of thenegative pressure circuit, such as, e.g. described in related,co-pending U.S. Provisional Application 62/714,229, filed Aug. 3, 2018and titled WOUND THERAPY SYSTEM WITH WOUND VOLUME ESTIMATION, the entiredisclosure of which is incorporated by reference herein. Accordingly, asillustrated by FIG. 4 , according to various embodiments, the NPWTsystem 100 may optionally include one or more features configured toenable to the NPWT system 100 to be used to estimate volume using anynumber of other methods in addition to the various methods of estimatingvolume during fluid instillation described herein.

For example, as illustrated in FIG. 4 , the NPWT system 100 may includefeatures similar to those described with reference to the varioussystems described in related, co-pending U.S. Provisional Application62/714,229. In particular, according to some embodiments, the tubingvalve 111 described with reference to the embodiment of FIG. 1 may bemodified, with the tubing valve 111′ of the embodiment of FIG. 4 beingconfigured to selectively permit and prevent fluid flow between theremoved fluid canister 106 and the wound site 114, thus allowing thenegative pressure circuit 200 to be selectively fluidly divided into aremoved fluid canister circuit (i.e. the portion of the negativepressure circuit located upstream of tubing valve 111′) and a wound sitecircuit (i.e. the portion of negative pressure circuit locateddownstream of tubing valve 111′). Referring again to FIG. 4 , accordingto some embodiments, the NPWT system 100 may also be provided with acalibrated leak system 113 configured to selectively control and measureairflow between tubing 110 and the ambient environment surroundingtherapy device 102. According to various embodiments, calibrated leaksystem 113 can be selectively opened to allow airflow into tubing 110 ata known, predetermined rate.

As illustrated by the block diagram of FIG. 2 , according to variousembodiments, the controller 118 may be configured to operate variouscomponents of therapy device 102. In particular, as will be described inmore detail below, according to various embodiments, the controller 118may be configured to control the various components of the NPWT system100 to execute one or more volume determination procedures via which,e.g. an estimated volume of the wound site 114 may be determined, thehealing progression of the wound site may be tracked, etc. According tovarious embodiments, the controller 118 may be configured such thatthese procedures may be performed with minimal user intervention and/orinput.

According to various embodiments, NPWT system 100 may include a varietyof sensors. For example, in some embodiments, one or more pressuresensors 115 may be located at any one or more of: in-line in the tubing110, at the wound dressing 112, at the removed fluid canister 106, atthe therapy device 102, at the pump 120, etc., so as to allow for themeasurement of pressure at any one or more of the removed fluid canister106, within the tubing 110 and/or at the wound site 114. Pressuremeasurements recorded by pressure sensor(s) 115 can be communicated tocontroller 118. According to various embodiments, controller 118 may usethe pressure measurements from pressure sensor(s) 115 as inputs tovarious pressure testing operations and control operations performed bycontroller 118.

In some embodiments, therapy device 102 includes a user interface 126.User interface 126 may include one or more buttons, dials, sliders,keys, or other input devices configured to receive input from a user.User interface 126 may also include one or more display devices (e.g.,LEDs, LCD displays, etc.), speakers, tactile feedback devices, or otheroutput devices configured to provide information to a user. Userinterface 126 can also display alerts generated by controller 118. Forexample, controller 118 can generate a “no canister” alert if canister106 is not detected.

In some embodiments, therapy device 102 includes a data communicationsinterface 124 (e.g., a USB port, a wireless transceiver, etc.)configured to receive and transmit data. Communications interface 124may include wired or wireless communications interfaces (e.g., jacks,antennas, transmitters, receivers, transceivers, wire terminals, etc.)for conducting data communications external systems or devices. Invarious embodiments, the communications may be direct (e.g., local wiredor wireless communications) or via a communications network (e.g., aWAN, the Internet, a cellular network, etc.). For example,communications interface 124 can include a USB port or an Ethernet cardand port for sending and receiving data via an Ethernet-basedcommunications link or network. In another example, communicationsinterface 124 can include a Wi-Fi transceiver for communicating via awireless communications network or cellular or mobile phonecommunications transceivers.

Methods of Use

Referring to FIG. 5 a flowchart detailing the steps of a method 500 ofusing a NPWT system 100 is shown according to an exemplary embodiment.As shown in FIG. 5 , at step 502, a NPWT system 100 (such as, e.g.,illustrated in FIG. 1 ) is provided, with the drape layer 117 and wounddressing 112 of the NPWT system 100 being positioned at the desiredwound site 114 to be treated. According to some embodiments, as a partof the initiation of treatment at step 502, and prior to proceeding withthe remaining steps of method 500, any number of different methods maybe used to confirm that the drape layer 117 and wound dressing 112 havebeen appropriately sealed about the wound site 114. For example,according to some embodiments, following the operation of the pneumaticpump 120 to evacuate of air from the wound site 114, pressure may bemonitored (e.g. using pressure sensor 115) to confirm the absence of anunintentional leak of air from the wound site 114. According to variousembodiments, the pressure that may be monitored may be any one or moreof the pressure within tubing 110, within the removed fluid canister106, at the therapy device 102, at the wound site 114, at the pump 120,etc. As will be understood, in other embodiments, this confirmation ofan appropriate seal between the wound dressing 112/drape layer 117 andthe wound site 114 may alternatively be performed as a part of and/orduring the subsequent steps of the method 500.

In addition to confirming the absence of leaks in the assembled NPWTsystem 100, according to some embodiments, step 502 may optionally alsoinclude the step of obtaining model data. The model data isrepresentative of changes in pressure over time as instillation fluid isinstilled to wound sites of varying volumes under a variety ofclinically relevant conditions and states (e.g. different instillationrates, wound volumes, dressing/foam characteristics, dressing air leakrates, starting pressures, predetermined target pressure, etc.). Suchmodel data may be generated using any number of, or combination ofvarious function approximators, statistical method, machine learningsystems, etc. The model data obtained at step 502 may include any numberof different pressure decay curves, functions, lookup tables, etc., andmay be obtained as pre-existing information that is input and stored bythe controller, and/or may be obtained and processed by the controller118 during an optional, initial training procedure conducted by thecontroller 118 prior to the use of the NPWT system 100 to treat woundsite 114 (e.g. prior to the initiation of method 500 or as part of theinitial setup of the NPWT system 100 at step 502). Non-limiting examplesof embodiments of training procedures by which such relationships may begenerated by the controller 118 are outlined in related, copending U.S.Provisional Application 62/650,132, filed Apr. 17, 2018 and titled WOUNDTHERAPY SYSTEM WITH WOUND VOLUME ESTIMATION, the entire disclosure ofwhich is incorporated by reference herein. As will be understood, inembodiments in which wound site 114 volume is additionally estimatedduring the purging of negative pressure within all or portions of thenegative pressure circuit 200, model data representative of changes inpressure over time as ambient air is allowed to flow into all orportions of the negative pressure circuit 200 under a variety ofclinically relevant conditions and states may additionally be obtainedin a substantially similar manner.

Once the set-up of the NPWT system 100 at step 502 is complete, at step504 the pneumatic pump 120 is operated (either manually or usingcontroller 118) to attain a predetermined negative pressure. After thepredetermined target pressure has been attained, the instillation pump122 (which may be the same as or different from pneumatic pump 120) isoperated at step 506 to instill instillation fluid 105 to the wound site114. Instillation fluid 105 is instilled to the wound site 114 at step506 until a predetermined target pressure has been attained. Accordingto various embodiments, the target pressure and/or predeterminednegative pressure may correspond to a pressure as measured at any one ormore of the tubing 110, the removed fluid canister 106, the therapydevice 102, at the wound site 114, the pump 120, etc. According tovarious embodiments, the predetermined target pressure may be betweenapproximately minus 15 mmHg and approximately 15 mmHg, more specificallybetween approximately minus 5 mmHg and 5 mmHg, and even morespecifically approximately 0 mmHg.

At step 508, the pressure decay (such pressure decay may be an increasein pressure over time), monitored at any one or more of the tubing 110,the removed fluid canister 106, the therapy device 102, at the woundsite 114, etc. during the instillation of instillation fluid 105 to thewound site 114 at step 506 may be used to estimate the volume of thewound site 114. According to some embodiments, the wound site 114 volumeestimation may be based on a comparison of the measured dynamic pressureduring the fluid instillation of step 506 to model pressure decay dataobtained prior to or during step 502. Because the wound site 114 volumeestimated at step 508 is estimated based on pressure decay observedduring the instillation of instillation fluid 105 to the wound site 114at step 506, as noted previously, the method 500 illustrated by theflowchart of FIG. 5 requires no additional steps and/or time than thatwhich would otherwise be required to instill the instillation fluid 105to the wound site 114. As step 510, the wound site 114 volume estimatedat step 508 may optionally be stored for future use.

Following the estimation of wound site 114 volume at step 508, the NPWTsystem 100 may continue to be used at step 512 to provide NPWT treatmentaccording to any number of different protocols. As illustrated by step512 of the method 500 of FIG. 5 , according to various embodiments, theNPWT treatment may continue with one or more cycles of negative pressureapplication and fluid instillation using the NPWT system 100, with step508 of estimating wound site 114 volume optionally being repeated aftersome, all or none of the additional step 504 of applying negativepressure to the wound site 114 and/or step 506 of instillinginstillation fluid 105 to the wound site 114.

The wound site 114 volume estimated using the method 500 of FIG. 5 maybe used for any number of different purposes. For example, as notedabove, according to some embodiments, the wound site 114 volumeestimated during an instillation phase of a NPWT treatment mayadvantageously be used to track the progress wound site 114 healing.Referring to FIG. 6 , a flowchart of a method 600 of monitoring woundsite 114 healing by utilizing estimated wound site 114 volumemeasurements obtained at a plurality of time points during the course ofa NPWT treatment using a NPWT system 100 is illustrated according to anexemplary embodiment. As shown FIG. 6 , at step 602, an initial woundsite 114 volume estimate is recorded at step 602, and may serve as abaseline against which subsequent wound site 114 volume estimates arecompared to track healing progress. According to various embodiments,estimation of the initial volume of the wound site 114 at step 602 maybe performed according to (or as) step 508 of the method 500 describedwith reference to FIG. 5 .

At step 604, the volume of the wound site 114 is estimated and recordedat one or more additional times during treatment (e.g., once per day)following the estimation of the initial wound site 114 volume at step602, with the times at which such one or more wound site 114 volumes areestimated and the values of the determined wound site 114 volume beingstored as data points within the memory of therapy device 102 and/orpresented to a user as an output of therapy device 102 (e.g., viacommunications interface 124 or user interface 126). In someembodiments, the estimated wound volume can be plotted as a function oftime.

The additional wound site 114 volumes estimated at one or moreadditional times over the course of treatment at step 604 may beestimated according to any number of different methods. For example,according to various embodiments, estimation of the volume of the woundsite 114 at step 604 may be performed according to (or as) step 508 ofthe method 500 of FIG. 5 during subsequent occurrences of fluidinstillation as part of the continued NPWT treatment of step 512.Alternatively, or additionally, one or more of the additional wound site114 volumes estimated at step 604 may be obtained according to any othermethods, such as, e.g. based on an observed dynamic pressure responsewithin a negative pressure circuit 200 of the NPWT system 100 during apurging even.

As additional wound site 114 volume estimates are obtained at steps 604,at step 606, changes in the estimated wound site 114 volume over timemay be used to determine healing progression of the wound site 114. Forexample, step 606 may include comparing wound site 114 volume estimatesobtained at step 604 to one or more previous estimates of the wound site114 volume (obtained at either step 604 or step 602) to identify achange in the wound site 114 volume. In some embodiments, step 606 mayadditionally include determining a rate at which the wound site 114 ishealing based on the changes in the estimated wound site 114 volume overtime. In some embodiments, step 606 may include extrapolating orpredicting a time at which wound site 114 will be fully healed based onthe series of wound site 114 volume estimates stored by the controller118. For example, step 606 may include predicting a time at which theestimated wound site 114 volume will reach zero (or another thresholdvalue) based on the initial wound site 114 volume estimated at step 1002and the series of additional wound site 114 volumes estimated at step604.

According to some embodiments, in addition to, or as an alternative to,the use of a wound site 114 volume estimates to monitor wound site 114healing progression (such as, e.g., described with reference to themethod 600 of FIG. 6 above), wound site 114 volume estimates may be usedto detect and/or prevent overfill of instillation fluid 105 to the woundsite 114 during an instillation of instillation fluid 105 to the woundsite 115.

Referring to the method 700 of preventing and/or detecting overfill ofinstillation fluid 105 to a wound site 115 during an instillation eventshown in FIG. 7 , the method 700 begins at step 702 with obtaining aninitial wound site 114 volume estimate. In embodiments in which theinstillation event of FIG. 7 corresponds to the instillation of fluidduring the continued NPWT treatment of step 512 described with referenceto the method 500 of FIG. 5 , the initial wound site 114 volume estimateobtained at step 702 may be equal to the wound site 114 volume estimatedat step 508 of the method 500 of FIG. 5 . In embodiments in which themethod 700 of FIG. 7 is performed following a previous iteration of themethod 700 of FIG. 7 , the wound site 114 volume estimate obtained atstep 702 may correspond to the wound site 114 volume estimated at step720 of the previous iteration of the method 700. In yet otherembodiments, the wound site 114 volume estimate obtained at step 702 maybe obtained according to any other number of other methods (such as,e.g. a volume estimated at step 810 of the method 800 of FIG. 8 ).

At step 704, the pneumatic pump 120 is operated to attain apredetermined negative pressure at any one or more of the tubing 110,the removed fluid canister 106, the therapy device 102, at the woundsite 114, the pump 120, etc., following which, at step 706 instillationfluid 105 is instilled to the wound site 114. As shown in FIG. 7 , asfluid is instilled to the wound site 114, according to some embodiments,pressure at any one or more of the tubing 110, the removed fluidcanister 106, the therapy device 102, at the wound site 114, the pump120, etc. may optionally be monitored in real-time at step 708. In suchembodiments, this measured real-time pressure may be compared against amodel pressure decay curve (such as described with reference to step 502in the method 500 of FIG. 5 above) representative of a volumecorresponding to the estimated wound site 114 volume obtained at step702 and the conditions under which instillation fluid 105 is beinginstilled to the wound site at step 706. As shown in FIG. 7 , in theevent that the measured real-time pressure decay does not correspond tothe expected pressure decay of the model pressure decay curve, at step710, the controller 118 may generate an alert to the user. In the eventthat the real-time pressure decay is changing at a rate that is greaterthan the expected rate, at step 712 the controller 118 may optionallyalso stop the instillation of instillation fluid 105 to the wound site114, so as to prevent an overfill of fluid.

As will be understood, the measured real-time pressure decay may varyfrom the expected pressure decay predicted by the model data for anynumber of reasons. For example, in embodiments in which the wound site114 has decreased in volume since the last time that the volume of thewound site 114 had been estimated, it is anticipated that pressure decayobserved as a result of the no w-smaller dimensioned wound site 114 willvary from the expected pressure decay predicted by the model data.Accordingly, in some embodiments, the controller 118 may be configuredto generate an alarm at step 710 and/or stop the instillation ofinstillation fluid 105 at step 712 only in the event that the differencebetween the measured pressure decay and the expected pressure decayexceeds a predetermined threshold. According to some embodiments, thisthreshold may correspond to a difference that is greater thanapproximately ±15 percent, and more specifically greater thanapproximately ±10 percent, and even more specifically greater thanapproximately ±5 percent.

If no difference between the real-time and expected pressure measurementis detected at step 708 (or if the difference does not exceed thepredetermined threshold), a determination is made at step 714 as towhether a predetermined target pressure has been attained at any one ormore of the tubing 110, the removed fluid canister 106, the therapydevice 102, at the wound site 114, the pump 120, etc. If the pressuremeasured has been determined to be substantially equal to thepredetermined target pressure, instillation of the instillation fluid1045 is stopped at step 716. According to various embodiments, thepredetermined target pressure at step 714 may be between approximatelyminus 15 mmHg and approximately 15 mmHg, more specifically betweenapproximately minus 5 mmHg and 5 mmH, and even more specificallyapproximately 0 mmHg.

According to some embodiments, if the target pressure has not yet beenattained at step 714, step 706 of instilling fluid to the wound site 114(and optionally step 708 of comparing monitored pressure to expectedpressure based on model data) may be repeated until it is determined atstep 714 that the target pressure has been attained.

However, as shown in FIG. 7 , according to some embodiments, the method700 may optionally include step 718, which may provide an additionallayer of safeguard against overfill for the NPWT system 100 in the eventthat the comparison of measured wound site 114 pressure to the targetpressure is insufficient to detect a potential overfill situation. Insuch embodiments, at step 718 a total volume of instillation fluid 105instilled to the wound site 114 since the initiation of step 706 may becompared against the wound site 114 volume estimate obtained at step702, with the instillation of instillation fluid 105 being stopped atstep 716 if the volume of instilled fluid is determined to besubstantially the same as the estimated wound site 114 volume. As willbe understood, by preventing the instillation of a volume of a quantityof instillation fluid 105 that exceeds the estimated volume of the woundsite 114, step 718 of the method 700 of FIG. 7 provides an additionallevel of protection against overfill for the NPWT system 100.Alternatively, if the volume of instilled instillation fluid 105 is lessthan the estimated wound site 114 volume, the method 700 may continue toinstill fluid to the wound site 114 at step 706.

According to some embodiments, at step 720, a current volume of thewound site 114 may optionally be estimated based on the most recentinstillation of fluid during step 706, with this most recent estimatedwound site 114 volume being stored at step 722 for any number of futureuses (e.g., for future instillations of fluid according to the method700 of FIG. 7 , to monitor healing of the wound site 114 according tothe method 600 of FIG. 6 , etc.). In situations in which theinstillation of fluid was stopped at step 716 in response to the targetpressure being determined to have been attained at step 714, the woundsite 114 volume may be estimated in a manner similar to that describedwith reference to step 508 of the method 500 of FIG. 5 , in which thepressure decay observed at any one or more of the tubing 110, theremoved fluid canister 106, the therapy device 102, at the wound site114, the pump 120, etc. during the instillation of fluid is compared tomodel pressure decay data to identify a corresponding volume of thewound site 114. If instillation of instillation fluid 105 was stopped atstep 716 in response to the volume of instilled fluid being determinedto be substantially equal to or greater than the estimated wound site114 volume at step 718, according to some embodiments, the wound site114 volume estimated at step 720 may correspond to the prior wound site114 volume estimate.

As noted above, according to some embodiments, it may be desirable toverify the wound site 114 volume estimated during instillation of fluidto the wound site 114 (such as, e.g., described with reference to themethod 500 of FIG. 5 and/or the method 700 of FIG. 7 ) against woundsite 114 volume estimates obtained according to any other number ofdifferent methods. Referring to FIG. 8 , an exemplary embodiment of onesuch method 800 of verifying a wound site 114 volume estimate obtainedduring fluid instillation against a wound site 114 volume estimatedaccording to another method, or vice versa, is illustrated. Morespecifically, in the method 800 illustrated by the flowchart of FIG. 8 ,a wound site 114 volume estimate based on a dynamic pressure responseobserved during a purging of various portions of the negative pressurecircuit 200 of a NPWT system 100 according to, e.g. the embodimentdescribed with reference to FIG. 4 , is compared against a wound site114 volume estimate based on fluid instillation to provide the NPWTsystem 100 with a higher confidence wound site 114 volume estimate.

As shown in FIG. 8 , according to one embodiment of method 800, thepneumatic pump 120 is operated at step 802 to attain a desired negativepressure within the negative pressure circuit 200. As will beunderstood, in embodiments in which tubing valve 111′ is in a closedconfiguration, step 802 may additionally include the step of opening thetubing valve 111′. Once the desired negative pressure has been attainedin the negative pressure circuit 200, the negative pressure circuit 200is purged by allowing air from the ambient environment to flow into thenegative pressure circuit 200 (e.g., via calibrated leak system 113)until a predetermined threshold pressure is attained within the negativepressure circuit 200. As the negative pressure circuit 200 is purgedduring step 804, pressure decay within the negative pressure circuit 200is monitored (using, e.g. pressure sensor(s) 115).

Once the predetermined threshold pressure has been attained within thenegative pressure circuit 200, the pneumatic pump 120 is once againoperated at step 806 to evacuate air from the negative pressure circuit200 to attain a desired negative pressure with the negative pressurecircuit 200. Once this desired negative pressure has been attained, thetubing valve 111′ is closed at step 808, thereby fluidly isolating theremoved fluid canister circuit from the wound site circuit.

At step 810, the removed fluid canister circuit is purged by allowingair from the ambient environment to flow into the removed fluid canistercircuit (e.g., via calibrated leak system 113) until a predeterminedthreshold pressure is attained within the removed fluid canistercircuit. As the removed fluid canister circuit is purged during step810, pressure decay within the removed fluid canister circuit ismonitored (using, e.g. pressure sensor 115). At step 812 a first volumeof the wound site 114 is estimated using the pressure decay observedwithin the negative pressure circuit 200 and the removed fluid canistercircuit during steps 804 and 810, respectively. More specifically, thevolume of the wound site 114 is calculated by comparing the observedpressure decays from steps 804 and 810 to model pressure decay data toidentify corresponding volumes representative of the volumes of thenegative pressure circuit 200 and removed fluid canister circuit, fromwhich the wound site 114 may subsequently be estimated. Non-limitingexamples of embodiments of additional methods of and/or systems viawhich wound site 114 volume at may be calculated using observed pressuredecay during purging of some or all of the negative pressure circuit 200as described with reference to steps 802-812 of the method 800 of FIG. 8are outlined in related, co-pending U.S. Provisional Application62/714,229, filed Aug. 3, 2018 and titled WOUND THERAPY SYSTEM WITHWOUND VOLUME ESTIMATION, the entire disclosure of which is incorporatedby reference herein.

At step 814, instillation fluid 105 is instilled to the wound site 114until a predetermined pressure has been attained at any one or more ofthe tubing 110, the removed fluid canister 106, the therapy device 102,at the wound site 114, the pump 120, etc., in a manner similar to thatdiscussed with reference to step 506 of the method 500 of FIG. 5 . Asecond wound site 114 volume is estimated at step 816 based on pressuredecay observed at any one or more of the tubing 110, the removed fluidcanister 106, the therapy device 102, at the wound site 114, the pump120, etc. during the instillation of fluid to the wound site 114 at step814, and in a manner similar to that described with reference to step508 of the method 500 of FIG. 5 . As will be understood, according tosome embodiments, steps 814 and 816 may optionally precede, oralternatively be performed simultaneously with, steps 810 and 812.

The first wound site 114 volume estimated at step 812 is compared atstep 818 to the second wound site 114 volume estimated at step 816. Ifthe first volume and second volume are determined to not besubstantially similar to one another at step 818, an alert may begenerated at step 820. If the first volume and second volume aredetermined to be substantially similar to one another at step 818, one,both, or an averaged value of the first wound site 114 volume estimateand second wound site 114 volume estimate are stored at step 822. Aswill be understood, any degree of similarity may be used to determinewhether the first volume and second volume are substantially similar toone another at step 818. According to some embodiments, the first volumeand second volume may be determined to be substantially similar to oneanother at step 818 if the first volume and second volume differ fromone another by approximately no more than 1.5 percent, more specificallyby approximately no more than 10 percent, and even more specifically byapproximately no more than 5 percent.

As will be understood, the method 800 of FIG. 8 may be performed anynumber of times, and at any point during the NPWT treatment providedusing the NPWT system 100. For example, according to some embodiments,the method 800 is performed upon an initial use of the NPWT system 100,following which the NPWT system 100 may be operated according to any ofthe methods disclosed herein, or any other number of different NPWTtreatment, or other treatment, protocols. In embodiments in which themethod 800 of FIG. 8 is followed by the method 700 of FIG. 7 , the woundsite 114 volume estimate obtained at step 702 during an initialiteration of method 700 may correspond to the wound site 114 volumeestimate stored at step 820 of method 800. In subsequent iterations ofmethod 700, the wound site 114 volume estimate obtained at step 702 maycorrespond to the wound site 114 volume stored at step 722 during theimmediately preceding iteration of method 700.

In other embodiments, some or all of the method 800 of FIG. 8 may berepeated any number of desired times. For example, in some embodiments,the cross-check between wound site 114 volume estimated based on purgingthe events of step 804 and 810 and wound site 114 volume estimated basedon fluid instillation of step 814 may be desired with each iteration ofthe method 800, in which embodiments the method 800 of FIG. 8 may berepeated in its entirety with each iteration. In other embodiments, itmay be desired to alternate estimation of wound site 114 volume based onthe purging events of step 804 and 810 with the estimation of wound site114 volume based on the fluid instillation at step 814. Additionally,according to various embodiments, (including those embodiments of FIG. 8discussed above) some or all of the iterations of the method 800 of FIG.8 may optionally incorporate some or all of the steps 708, 710, 712,714, 716, 718, and 720 of the method 700 of FIG. 700 between steps 815and 816. According to various embodiments, the method 600 of monitoringwound site 114 healing of FIG. 6 may also be incorporated into any ofthe methods disclosed herein.

In general, the volume of the wound site 114 is defined by the entiretyof the interior extending between the wound site 114 and the drape layer117 attached to the skin 116 about the wound site 114. At various pointsduring treatment using the NPWT system 100, located within and definingthe volume of the wound site may be any one of, and any combination of:the wound dressing 112, fluid 121, and/or dead space 119. As will beunderstood, unless the wound dressing 112 is replaced during treatment,the volume of the wound site 114 volume occupied by the wound dressing112 will generally remain unchanged over the course of treatment,whereas the portion of the wound site 114 volume occupied by the fluid121 and/or dead space 119 may change with time.

As will be understood, according to various embodiments, the controller118 may be programmed to allow the NPWT system 100 to determine volumerelative to the wound site 114 using any or all of the methods describedherein.

Configuration of Exemplary Embodiments

The construction and arrangement of the systems and methods as shown inthe various exemplary embodiments are illustrative only. Although only afew embodiments have been described in detail in this disclosure, manymodifications are possible (e.g., variations in sizes, dimensions,structures, shapes and proportions of the various elements, values ofparameters, mounting arrangements, use of materials, colors,orientations, etc.). For example, the position of elements can bereversed or otherwise varied, and the nature or number of discreteelements or positions can be altered or varied. Accordingly, all suchmodifications are intended to be included within the scope of thepresent disclosure. The order or sequence of any process or method stepscan be varied or re-sequenced according to alternative embodiments.Other substitutions, modifications, changes, and omissions can be madein the design, operating conditions and arrangement of the exemplaryembodiments without departing from the scope of the present disclosure.

The present disclosure contemplates methods, systems and programproducts on any machine-readable media for accomplishing variousoperations. The embodiments of the present disclosure can be implementedusing existing computer processors, or by a special purpose computerprocessor for an appropriate system, incorporated for this or anotherpurpose, or by a hardwired system. Embodiments within the scope of thepresent disclosure include program products comprising machine-readablemedia for carrying or having machine-executable instructions or datastructures stored thereon. Such machine-readable media can be anyavailable media that can be accessed by a general purpose or specialpurpose computer or other machine with a processor. By way of example,such machine-readable media can comprise RAM, ROM, EPROM, EEPROM, CD-ROMor other optical disk storage, magnetic disk storage or other magneticstorage devices, or any other medium which can be used to carry or storedesired program code in the form of machine-executable instructions ordata, structures and which can be accessed by a general purpose orspecial purpose computer or other machine with a processor. Combinationsof the above are also included within the scope of machine-readablemedia. Machine-executable instructions include, for example,instructions and data which cause a general-purpose computer, specialpurpose computer, or special purpose processing machines to perform acertain function or group of functions.

Although the figures show a specific order of method steps, the order ofthe steps may differ from what is depicted. Also, two or more steps canbe performed concurrently or with partial concurrence. Such variationwill depend on the software and hardware systems chosen and on designerchoice. All such variations are within the scope of the disclosure.Likewise, software implementations could be accomplished with standardprogramming techniques with rule-based logic and other logic toaccomplish the various connection steps, processing steps, comparisonsteps and decision steps.

1.-14. (canceled)
 15. A wound therapy system comprising: a pump; a wounddressing configured to be applied to a wound site; a fluid tube fluidlyconnecting the pump to the wound dressing; and a controller configuredto: monitor pressure during instillation of a fluid to the wound site;and determine a volume of the fluid instilled to the wound site usingpressure measurements obtained from the monitored pressure during theinstillation of the fluid to the wound site.
 16. The wound therapysystem of claim 15, wherein the controller is configured to determinethe volume of the fluid instilled to the wound by comparing the obtainedpressure measurements to model pressure decay data.
 17. The woundtherapy system of claim 15, wherein the controller is configured todetermine a volume of a fluid instilled to the wound site at each of oneor more instillation events occurring during treatment of the woundsite.
 18. The wound therapy system of claim 15, further comprising asource of instillation fluid, the controller further being configured tooperate the pump to instill the fluid to the wound site.
 19. The woundtherapy system of claim 18, wherein the controller is configured to stopthe instillation of the fluid to the wound site when a firstpredetermined pressure has been detected.
 20. The wound therapy systemof claim 15, wherein the controller is further configured to: operatethe pump to evacuate air from the wound site to attain a predeterminednegative pressure; upon detecting that a pressure is equal to thepredetermined negative pressure, operate the pump to instill a fluid tothe wound site; and stop the instillation of fluid to the wound siteupon detection that a measured pressure is equal to a predeterminedtarget pressure.
 21. A wound therapy system comprising: a pump; a wounddressing configured to be applied to a wound site; a fluid tube fluidlyconnecting the pump to the wound dressing; a source of instillationfluid; and a controller configured to: operate the pump to instill theinstillation fluid to the wound site; monitor pressure duringinstillation of the instillation fluid to the wound site; and stop theoperation of the pump in response to detection of a first predeterminedpressure.
 22. The wound therapy system of claim 32, wherein thecontroller is configured to obtain pressure measurements based on thepressure monitored during the operation of the pump to instillinstillation fluid to the wound site.
 23. The wound therapy system ofclaim 22, wherein the controller is configured to obtain model pressuredecay data representative of pressure decay within a container having avolume equal to the estimated volume of the wound site as instillationfluid is instilled into the container.
 24. The wound therapy system ofclaim 23, wherein the controller is further configured to compare thepressure measurements to the model pressure decay data in real-time. 25.The wound therapy system of claim 21, wherein the controller is furtherconfigured to: operate the pump to evacuate air from the wound site;monitor pressure as air is evacuated from the wound site; and stopoperation of the pump when a predetermined negative pressure has beendetected.
 26. The wound therapy system of claim 25, wherein thecontroller is configured to operate the pump to instill the instillationfluid to the wound site after the predetermined negative pressure hasbeen detected.
 27. The wound therapy system of claim 26, wherein thecontroller is configured to estimate a volume of the instillation fluidinstilled to the wound site using pressure measurements obtained fromthe monitored pressure during instillation of the fluid to the woundsite.
 28. The wound therapy system of claim 27, wherein the controlleris configured to compare the obtained pressure measurements to modelpressure decay data to determine the volume of the instillation fluidinstilled to the wound site.
 29. The wound therapy system of claim 28,wherein the controller is further configured to: obtain an estimate of avolume of the wound site; compare the estimated volume of the wound siteto the determined volume of the instillation fluid instilled to thewound site; and generate an alarm if the estimated volume of the woundsite is not substantially the same as the determined volume of theinstillation fluid instilled to the wound site.
 30. The wound therapysystem of claim 17, wherein the controller is configured to store eachof the determined volumes.
 31. The wound therapy system of claim 30,wherein the controller is configured to monitor healing of the woundsite based on the stored determined volumes.
 32. The wound therapysystem of claim 21, wherein the controller is configured to obtain anestimated volume of the wound site prior to operating the pump toinstill fluid to the wound site.
 33. The wound therapy system of claim24, wherein an alarm is generated if the measured pressure does notcorrespond to the model pressure decay data.
 34. The wound therapysystem of claim 28, wherein the model pressure decay data isrepresentative of pressure decay within a container having a knownvolume during instillation of a fluid into the container.